HomeINBX • NASDAQ
add
Inhibrx Biosciences Inc
$76.21
Makalipas ang Oras ng Trabaho:(0.00%)0.00
$76.21
Sarado: Dis 15, 4:01:21 PM GMT-5 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$79.57
Sakop ng araw
$74.80 - $81.52
Sakop ng taon
$10.81 - $94.47
Market cap
1.11B USD
Average na Volume
270.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 5.28M | -33.24% |
Net na kita | -35.26M | 19.62% |
Net profit margin | — | — |
Kita sa bawat share | -2.28 | 19.72% |
EBITDA | -33.23M | 27.82% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 153.09M | -22.03% |
Kabuuang asset | 177.47M | -20.26% |
Kabuuang sagutin | 140.64M | 218.95% |
Kabuuang equity | 36.83M | — |
Natitirang share | 14.54M | — |
Presyo para makapag-book | 31.33 | — |
Return on assets | -43.39% | — |
Return on capital | -52.98% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -35.26M | 19.62% |
Cash mula sa mga operasyon | -33.82M | -11.70% |
Cash mula sa pag-invest | -7.00K | 97.17% |
Cash mula sa financing | 352.00K | — |
Net change in cash | -33.48M | -9.67% |
Malayang cash flow | -22.71M | -39.24% |
Tungkol
Itinatag
2024
Headquarters
Website
Mga Empleyado
159
